Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

This study looks at how a new medicine called lunsekimig helps adults with asthma. Asthma is a condition where it's hard to breathe because the airways in the lungs get swollen. Placebo is a dummy medicine that doesn't have any active ingredients, used to compare how well the real medicine works. In this study, you won't know if you're getting the real medicine or the placebo (this is called double-blind).

To join, you must be 18 to 80 years old with mild-to-moderate asthma diagnosed by a doctor. You shouldn't have other severe lung diseases or recent serious asthma problems. The study lasts about 64 weeks, and you may have up to 18 visits. The medicine is given as an SC injection, which means it's a shot under the skin.

• The study lasts for over a year (64 weeks).
• You will have 18 visits for tests and checkups.
• Make sure you don’t have other serious lung diseases to join.